Who We Are
Terumo (TSE:4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for more than 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. Founded as a Japanese thermometer manufacturer in 1921, Terumo has been supporting healthcare around the world ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.
Introducing Terumo Group
Corporate Profile
| Company Name | Terumo Corporation |
| Head Office | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, 151-0072 Japan Tel. +81-3-3374-8111 |
| Date of Establishment | 1921 |
| Corporate Stock | Prime Market of Tokyo Stock Exchange (Code: 4543) |
| Capital Stock | 38.7 billion yen |
| Revenue | 820.2 billion yen (for FYE Mar. 2023) The Latest Financial Results > |
| Representative Directors | Toshiaki Takagi, Chairman of the Board Hikaru Samejima, President and Chief Executive Officer |
| Number of Employees | 30,207 (Consolidated) |
| Main Business | Manufacturing and sales of medical products and equipment, including pharmaceuticals, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital thermometers. |
| Global Network | Global Network > |
Corporate Guide Brochure
